BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Psoriasis Council - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:International Psoriasis Council
X-ORIGINAL-URL:https://psoriasiscouncil.org
X-WR-CALDESC:Events for International Psoriasis Council
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Atlantic/Faroe
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231213T063000
DTEND;TZID=America/New_York:20231213T073000
DTSTAMP:20260517T064640
CREATED:20230809T193103Z
LAST-MODIFIED:20231227T195717Z
UID:10000163-1702449000-1702452600@psoriasiscouncil.org
SUMMARY:Global Webinar 4: Psoriasis and the Gut
DESCRIPTION:Agenda\nWelcome and Introduction\nAkimichi Morita\, MD\, PhD\, Japan \nGenetic Insights into IBD and Psoriasis: Shared Features and Unique Characteristics\nAlex Tsoi\, MS\, PhD\, United States \nImmunopathogenesis of IBD: Pathways and Therapeutic Challenges\nKiyoshi Takeda\, MD\, PhD\, Japan \nCase Study: The Complex Relationship between IBD and Psoriasis\nFrancis Lai\, MBBS\, FACD\, Australia \nPanel Discussion\nFaculty \nClosing Comments and Adjourn\nAkimichi Morita\, MD\, PhD\, Japan \n  \nProgram Chair\n \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio
URL:https://psoriasiscouncil.org/event/global-webinar-4-psoriasis-and-the-gut/
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Rome:20231110T091500
DTEND;TZID=Europe/Rome:20231110T120000
DTSTAMP:20260517T064640
CREATED:20230919T191605Z
LAST-MODIFIED:20240515T112557Z
UID:10000169-1699607700-1699617600@psoriasiscouncil.org
SUMMARY:IPC & ARDV Symposium: Psoriasis - A Complex Disease of All Ages
DESCRIPTION:Agenda\nPART ONE \nThe Epidemiology of Psoriasis; Insights in Children and Older Adults \nLuigi Naldi\, MD\, Italy \nPsoriasis in Children: Diagnosis. Clinical Presentations\, Comorbidities. Available Treatments \nEmmanuel Mahé\, MD\, PhD\, France \nPatient Registry Data on the Treatment of Psoriasis in Children\nMarieke Seyger\, MD\, PhD\, Netherlands \nTreating Severe Psoriasis in Adult Patients with Severe Psoriasis Less Than 60 Years Old- A Personalized Approach\nMenno de Rie\, MD\, PhD\, Netherlands \nTreating Severe Psoriasis in Patients Over 60 Years Old – The Interplay Between Immunosenescence and Psoriasis\nLluis Puig\, MD\, PhD\, Spain \nDiscussion \nPART TWO \nPsoriasis – Interesting Cases Presented By Residents\n1. Clinical Case 1\n2. Clinical Case 2\n3. Clinical Case 3\n4. Clinical Case 4\n5. Clinical Case 5 \nCLOSING COMMENTS AND ADJOURN \nProgram Chair\n \n						Bio\n		 \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\n  \nSymposium jointly presented with:
URL:https://psoriasiscouncil.org/event/symposium-ardv2023/
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2023/09/ARDV-2023-Event-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20231011T083000
DTEND;TZID=Europe/Paris:20231011T114500
DTSTAMP:20260517T064640
CREATED:20220828T011305Z
LAST-MODIFIED:20231120T190851Z
UID:10000154-1697013000-1697024700@psoriasiscouncil.org
SUMMARY:Symposium: Innovations in the Pathogenesis and Treatment of Psoriasis
DESCRIPTION:Agenda\nWELCOME AND INTRODUCTION\nLluís Puig\, MD\, PhD\, Spain \nSESSION ONE: UPDATES ON THE PATHOGENESIS OF PSORIASIS \nNew Insights in the Pathogenesis of Psoriasis\nJohann Gudjonsson\, MD\, PhD\, United States \nUpdates on the Pathogenesis and Treatment of Generalized Pustular Psoriasis\nHervé Bachelez\, MD\, PhD\, France \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator \nSESSION TWO: DISEASE RELAPSE AND PROGRESSION \nNew Understandings of Disease Relapse and Progression\nIrène Gallais Sérézal\, MD\, PhD\, France \nThe Natural History of Psoriasis: Insights into Clinical and Genetic Markers\nAxel Svedbom\, MSc\, PhD\, Sweden \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator \nBREAK \nSESSION THREE: TREATMENT INNOVATIONS \nNew Paradigms in Oral Treatments for Psoriasis\nRichard Warren\, BSc\, MBChB\, MRCP\, PhD\, United Kingdom \nTYK2 Inhibitors for the Treatment of Psoriasis\nRonald Vender\, MD\, FRCPC\, Canada \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator\nRichard Warren\, BSc\, MBChB\, MRCP\, PhD\, United Kingdom\, moderator \nCLOSING COMMENTS AND ADJOURN\nLluís Puig\, MD\, PhD\, Spain \n  \nProgram Chair\n \n						Bio\n		\n  \nProgram Co-Chairs\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\n  \nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio
URL:https://psoriasiscouncil.org/event/symposium-eadv2023/
LOCATION:Messe Berlin Congress Center | Room 5\, Level 1
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/EADV-2023-Event-Logo.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230928T090000
DTEND;TZID=America/New_York:20230928T100000
DTSTAMP:20260517T064640
CREATED:20230516T180852Z
LAST-MODIFIED:20231120T191955Z
UID:10000162-1695891600-1695895200@psoriasiscouncil.org
SUMMARY:Global Webinar 3: Psoriasis and the Joints
DESCRIPTION:Agenda\nWelcome and Introduction\nLone Skov\, MD\, PhD\, Denmark \nEarly Signs and Markers of Psoriatic Arthritis and Disease Progression\nBent Deleuran\, MD\, PhD\, Denmark \nWhat’s New in Treatments for Psoriatic Arthritis\nFrank Behrens\, MD\, Germany \nDoes Treatment of Psoriasis Prevent Development of Psoriatic Arthritis?\nAlexis Ogdie\, MD\, MSCE\, United States \nQ & A and Closing Comments \nLone Skov\, MD\, PhD\, Denmark \n  \nProgram Chair\n \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\n  \nThis symposium is supported in part by Eli Lilly and Company.
URL:https://psoriasiscouncil.org/event/global-webinar-3-psoriasis-and-the-joints/
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Atlantic/Faroe:20230908T090000
DTEND;TZID=Atlantic/Faroe:20230908T170000
DTSTAMP:20260517T064640
CREATED:20230831T174423Z
LAST-MODIFIED:20231120T191223Z
UID:10000164-1694163600-1694192400@psoriasiscouncil.org
SUMMARY:Virtual Gunnar Lomholt Symposium
DESCRIPTION:Agenda\nWelcome and Program Overview\nLone Skov\, MD\, PhD\, Denmark \nGunnar Lomholt’s Story and Thesis \nClaus Zachariae\, MD\, DMSci\, Denmark \nBig Data and Implications to Psoriasis \nTamar Nijsten\, MD\, PhD\, Netherlands \nWhat Genetic Association Tells Us About Phenotype: HLA and Beyond\nMichael Simpson\, MSc\, PhD\, United Kingdom \nBREAK \nComorbidities and Their Causal Relationship\nAlex Tsoi\, MS\, PhD\, United States \nLinking Genetics with Biological Mechanisms\nJohann Gudjonsson\, MD\, PhD\, United States \nKEYNOTE: A Genetic Epidemiologic History of Psoriasis\nJames T. Elder\, MD\, PhD\, United States \nBREAK \nPART TWO \nInflammatory Memory in Psoriasis\nLiv Eidsmo\, MD\, PhD\, Denmark \nImmunogenetic Dissection of Pustular Forms of Psoriasis\nHervé Bachelez\, MD\, PhD\, France \nKEYNOTE: Where is Psoriatic Arthritis Heading?\nOliver Fitzgerald\, MBBCh\, BAO\, MRCPI\, MRCP\, FRCPI\, MD\, Ireland \nThe History of the Faroe Islands\nErland Viberg Joensen\, PhD\, Faroe Islands \nBREAK \nScience and Practice of Therapeutic Drug Monitoring\nCatherine Smith\, MD\, United Kingdom \nTreatment Strategies and Targets for Severe Psoriasis\nUlrich Mrowietz\, MD\, Germany \nThe Need for Real World Evidence\nLone Skov\, MD\, PhD\, Denmark \n60 Years of Psoriasis Therapy: How Things Have Changed\nMatthias Augustin\, MD\, Germany \nClosing Comments and Adjourn\nJonathan Barker\, MD\, FRCP\, United Kingdom \nScientific Committee\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\nFaculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio
URL:https://psoriasiscouncil.org/event/virtual-gunnar-lomholt-symposium/
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Singapore:20230703T143000
DTEND;TZID=Asia/Singapore:20230703T173000
DTSTAMP:20260517T064640
CREATED:20220828T010430Z
LAST-MODIFIED:20230911T191129Z
UID:10000153-1688394600-1688405400@psoriasiscouncil.org
SUMMARY:Symposium: Psoriasis Management and Treatment – An International Perspective
DESCRIPTION:Agenda\nWELCOME AND INTRODUCTION\nSiew Eng Choon\, MBBS\, FRCP\, Malaysia \nA Patient-Inclusive Approach in the Treatment of Psoriasis: A Principal Without Borders\nClaudia de la Cruz\, MD\, Chile \nAn International Perspective on Value-Based Healthcare\nJo Lambert\, MD\, PhD\, Belgium \nGenetic Differences Across the Globe\nJohann Gudjonsson\, MD\, PhD\, United States \nPitfalls in Diagnosis and Phenotypic Differences Related to Skin of Color\nMohammad Huq\, MBBS. DDSc\, MSc-Dermatology\, MPH\, Bangladesh \nBREAK \nTherapeutic Challenges Related to Skin of Color\nMahira El Sayed\, MSc\, MD\, Egypt \nComorbidities of Psoriasis Across the World\nKathleen Gallant\, MPA\, United States \nAvailability of Therapies Across the World: Data from the GPA\nChris Griffiths\, OBE\, MD\, FMedSci\, United Kingdom \nEvery Patient in the World has the Right to Optimal Treatment \nHoseah Waweru\, MD\, Kenya \nCLOSING COMMENTS AND ADJOURN\nClaudia de la Cruz\, MD\, Chile \n  \nProgram Chairs\n \n						Bio\n		 \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\n  \nThis Symposium is supported in part by Bristol Myers Squibb and Eli Lilly and Company.
URL:https://psoriasiscouncil.org/event/symposium-wcd2023/
LOCATION:Suntec Singapore Convention & Exhibition Centre | Room Nicoll 1\, Level 3
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/WCD-Event-Logo.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230526T130000
DTEND;TZID=America/New_York:20230526T160000
DTSTAMP:20260517T064640
CREATED:20221114T012258Z
LAST-MODIFIED:20230911T190932Z
UID:10000156-1685106000-1685116800@psoriasiscouncil.org
SUMMARY:IPC & SOLAPSO Symposium: Advances in the Management of Psoriasis
DESCRIPTION:Agenda\nPART ONE: MANAGEMENT OF HARD TO TREAT AREAS\nWelcome and Introduction to the IPC and SOLAPSO\nRicardo Romiti\, MD\, PhD\, Brazil & Fernando Valenzuela\, MD\, Chile \nAdvances in the Management of Scalp Psoriasis\nClaudia de la Cruz\, MD\, Chile \nHow I Treat the Scalp\nCésar Gonzalez\, MD\, Colombia \nAdvances in the Management of Nail Psoriasis\nEnrique Rivas\, MD\, Guatemala \nHow I Treat the Nails\nFernando Valenzuela\, MD\, Chile \nAdvances in the Management of Palmoplantar Psoriasis\nAnber Tanaka\, MD\, Brazil \nHow I Treat the Palms and Soles\nMarcelo Arnone\, MD\, Brazil \nPanel Discussion\nRicardo Romiti\, MD\, PhD\, Brazil – facilitator \nBREAK\nPART TWO: KEEP UP TO DATE: PSORIASIS IN 2023\nMethotrexate: What Have We Learned in 75 Years\nAngela Londoño\, MSc\, MD\, Colombia \nCLCI in Patients with Psoriasis\nRicardo Romiti\, MD\, PhD\, Brazil \nGPP: Still a Neglected Disease?\nJuan Raul Castro Ayarza\, MD\, Colombia \nWhat´s the Role of Small Molecules in the Treatment of Psoriasis?\nGabriel Magariños\, MD\, Argentina \nNew Biologics\nAndré Esteves de Carvalho\, MD\, PhD\, Brazil \nPanel Discussion\nEnrique Rivas\, MD\, Guatemala – facilitator \n\nAttendees must be registered for the RADLA meeting to attend. Register now!\nProgram Chairs\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\n  \nSymposium jointly presented with:\n \n  \nThis Symposium is supported in part by Bristol Myers Squibb.
URL:https://psoriasiscouncil.org/event/radla-2023-agenda/
LOCATION:Viasoft (UP Expo) – Curitiba\, Room Number 09\, Located at ASA 3
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/11/RADLA-2023-Event-Logo.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Tokyo:20230510T113000
DTEND;TZID=Asia/Tokyo:20230510T150000
DTSTAMP:20260517T064640
CREATED:20220827T191253Z
LAST-MODIFIED:20230911T191004Z
UID:10000152-1683718200-1683730800@psoriasiscouncil.org
SUMMARY:Symposium: Disease Memory and Disease Modification in Psoriasis
DESCRIPTION:Agenda\nPART ONE: LECTURES \nWelcome and Introduction\nJohann Gudjonsson\, MD\, PhD\, United States \nTissue Resident Memory Cells\nRachael Clark\, MD\, PhD\, United States \nEpigenetic Inflammatory Memory\nLiv Eidsmo\, MD\, PhD\, Denmark \nDisease Modification\nCurdin Conrad\, MD\, Switzerland \nFuture Directions in Psoriasis Research\nNicole Ward\, PhD\, United States \nPanel Discussion\nJohann Gudjonsson\, MD\, PhD\, United States – facilitator \nBREAK \nPART TWO: POSTER PRESENTATIONS \nIntroduction to Poster Presentations\nCurdin Conrad\, MD\, Switzerland \nUncovering Antigen Triggers in Genetically Predisposed Psoriasis Patients\nAsolina Braun\, PhD – Monash University\, Melbourne\, Australia \nThe Clinical and Immunological Features of Immune Checkpoint Inhibitors-Related Psoriasis\nLai-Ying Lu\, MD – Department of Dermatology and Aesthetic Medicine Center\, Jen-Ai Hospital\, Taichung\, Taiwan & Chang Gung Memorial Hospital\, Linkou\, Taoyuan\, Taiwan \nDNA Methyltransferase DNMT1 Deficiency in Keratinocyte Ameliorates IMQ-Induced Psoriasis-Like Dermatitis\nChunyuan Guo – Shanghai Skin Disease Hospital\, Tongji University School of Medicine\, Shanghai\, China \nIxekizumab Reduces Key IL-17 And IL-23 Pathway Genes More Rapidly Than Guselkumab\nLam Tsoi\, PhD – University of Michigan\, Ann Arbor\, Michigan\, United States \nComparative Efficacy of Biologic and Oral Agents in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis\nWilson Liao\, MD – University of California San Francisco\, San Francisco\, California\, United States \nEpidermal Keratinocytes from Psoriatic Resolved Skin Keep Disease Residual Transcriptomic and Epigenomic Profiles\nAmeneh Ghaffarinia\, MD – University of Szeged\, Szeged\, Hungary \nEarly Intervention with Secukinumab May Affect the Establishment of Tissue Memory in Psoriasis\nJohann Gudjonsson\, MD\, PhD – University of Michigan\, Ann Arbor\, Michigan\, United States \nRNA-Seq Helps Elucidate the Mechanism Of NB-UVB Through Comparison of The Treated Edges and Centers of Psoriatic Plaques\nSuphagan Boonpethkaew\, MD – Thammasat University\, Bangkok\, Thailand \nClosing Comments and Adjourn\nCurdin Conrad\, MD\, Switzerland \n\nAttendees must be registered for the ISID meeting to attend. Register now!\n  \nProgram Chairs\n \n						Bio\n		 \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio
URL:https://psoriasiscouncil.org/event/symposium-isid2023/
LOCATION:Keio Plaza Hotel Tokyo\, Room C (Nishiki) – 4F (south tower)
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/ISID-Event-Logo.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230418T153000
DTEND;TZID=Europe/Paris:20230418T163000
DTSTAMP:20260517T064640
CREATED:20230221T015321Z
LAST-MODIFIED:20230502T183440Z
UID:10000160-1681831800-1681835400@psoriasiscouncil.org
SUMMARY:Global Webinar 2: Psoriasis in Patients with Cancer or Chronic Infections
DESCRIPTION:Agenda\nWelcome and Introduction\nLluís Puig\, MD\, PhD\, Spain \nPsoriasis and Cancer: Epidemiologic Association\nLone Skov\, MD\, PhD\, Denmark \nPsoriasis Treatment and Cancer: New Perspectives\nPaolo Gisondi\, MD\, Italy \nPsoriasis Treatment and Chronic Infections\nRicardo Romiti\, MD\, PhD\, Brazil \nQ & A and Closing Comments \nLluís Puig\, MD\, PhD\, Spain \n  \nProgram Chair\n \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio
URL:https://psoriasiscouncil.org/event/psoriasis-in-patients-cancer-chronic-infections/
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20230316T140000
DTEND;TZID=America/Chicago:20230316T170000
DTSTAMP:20260517T064640
CREATED:20230214T200125Z
LAST-MODIFIED:20230425T184240Z
UID:10000151-1678975200-1678986000@psoriasiscouncil.org
SUMMARY:Symposium: Psoriasis: Using the Right Treatment in the Right Patient at the Right Time
DESCRIPTION:Agenda\nPART ONE: LECTURES \nWelcome and Introduction\nPeter van de Kerkhof \nPrecision Medicine\, Including Early Active Intervention \nChristopher Griffiths \nCutting Edge Topical Medications\nLinda Stein Gold \nCutting Edge Systemic Treatments: Oral and Biologic\nAlexander Egeberg \nConsidering Comorbidities in Treatment Planning \nAndrew Blauvelt \nPanel Discussion \nLinda Stein Gold\, facilitator \nBREAK \nPART TWO: CHALLENGING CASES \nChallenging Case 1: A Patient with GPP\nJaquelini Barboza da Silva \nChallenging Case 2: A Patient with Multiple Comorbidities\nÁlvaro González-Cantero \nChallenging Case 3: A Patient with Active Cancer\nMatt Vesely \nQ & A – Speaker Panel\nPeter van de Kerkhof\, facilitator \nCLOSING COMMENTS AND ADJOURN\nPeter van de Kerkhof \n  \nProgram Chairs\n \n						Bio\n		 \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\nCase Presenters\n \n						Bio\n		 \n						Bio\n		 \n						Bio\n		\n\nThis symposium is supported in part by \nLead Sponsors \n              \n Supporting Sponsor\n \n  \nThe content of this session and opinions expressed by presenters are those of the respective presenting society or presenters and do not represent an endorsement by\, nor imply that the session content has been evaluated or approved by the American Academy of Dermatology or corporate sponsors.
URL:https://psoriasiscouncil.org/event/symposium-aad2023/
LOCATION:New Orleans Ernest N. Morial Convention Center | Room 275/276/277\, Floor 2
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/06/AAD-Event.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230119T153000
DTEND;TZID=Europe/Paris:20230119T163000
DTSTAMP:20260517T064640
CREATED:20221116T014532Z
LAST-MODIFIED:20230220T200514Z
UID:10000157-1674142200-1674145800@psoriasiscouncil.org
SUMMARY:Global Webinar 1: Current Knowledge and Future Directions: Psoriasis and Heart Disease
DESCRIPTION:Agenda\nWelcome and Introduction \nAndy Blauvelt \nPathophysiologic Links Between Psoriasis and Heart Disease \nMichael Garshick \nExploring Whether Systemic Therapy for Psoriasis Improves Heart Disease in Clinical Trials \nJoel Gelfand \nInvestigating Real-World Databases to Determine Whether Systemic Therapy for Psoriasis Improves Heart Disease  \nMona Ståhle \nQ & A and Closing Comments  \nAndy Blauvelt \n  \nProgram Chair\n \n						Bio\n		\nProgram Faculty\n \n						Bio\n		 \n						Bio\n		 \n						Bio
URL:https://psoriasiscouncil.org/event/gw1-psoriasis-heart-disease/
CATEGORIES:Past Events - 2023
ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif
END:VEVENT
END:VCALENDAR